Jonghyuck Won

Reporter

Biowatch Team I majored in medicine and have been covering the healthcare industry for 15 years. I will observe, listen, and report without bias.

mail every83@kormedi.com

Latest Articles

VOYXACT Preserves Kidney Function for Two Years in Phase 3 IgA Nephropathy Trial

CAR-T Without Extracting Patient Cells? J&J Makes $785 Million Bet on In Vivo Therapy

South Korea Ranks in GSK’s Global Top 10 for Clinical Research, with Over 70 Trials Underway

Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven

GSK Wins Early FDA Approval for Oral Lung Cancer Drug Jideytro Following $10.6 Billion Nuvalent Acquisition

Biogen Korea Taps Pharma Veteran Kim Chul-woong as New Country Lead

Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market